taurocholic acid has been researched along with Clostridioides difficile Infection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brito-Silva, C; Castro-Córdova, P; Cofré-Araneda, G; Kuehne, SA; Mendoza-León, MJ; Minton, NP; Mora-Uribe, P; Orozco-Aguilar, J; Paredes-Sabja, D; Pizarro-Guajardo, M; Reyes-Ramírez, R | 1 |
| Kyne, L; Martin, A; Moore, P; Solomon, K | 1 |
| Citron, DM; Goldstein, EJ; Leoncio, ES; Merriam, CV; Tyrrell, KL | 1 |
| Abel-Santos, E; Howerton, A; Patra, M | 1 |
| Foster, NF; Riley, TV | 1 |
5 other study(ies) available for taurocholic acid and Clostridioides difficile Infection
| Article | Year |
|---|---|
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection.
Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Cell Line; Clostridioides difficile; Clostridium Infections; Collagen; Endocytosis; Epithelial Cells; Female; Fibronectins; Humans; Integrins; Intestinal Mucosa; Intestines; Male; Mice, Inbred C57BL; Nystatin; Protein Binding; Recurrence; Spores, Bacterial; Taurocholic Acid; Vitronectin | 2021 |
Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure.
Topics: Clostridioides difficile; Clostridium Infections; Culture Media; Humans; Recurrence; Ribotyping; Severity of Illness Index; Species Specificity; Spores, Bacterial; Taurocholic Acid; Treatment Failure | 2013 |
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples.
Topics: Agar; Animals; Anti-Infective Agents; Cefoxitin; Clostridioides difficile; Clostridium Infections; Culture Media; Cycloserine; Erythrocytes; Feces; Fructose; Horses; Humans; Mannitol; Muramidase; Taurocholic Acid | 2013 |
Fate of ingested Clostridium difficile spores in mice.
Topics: Animals; Bacterial Toxins; Caco-2 Cells; Cecum; Cell Death; Cell Membrane Permeability; Chlorocebus aethiops; Clostridioides difficile; Clostridium Infections; Cytoprotection; Feces; Humans; Hydrolases; Intestines; Mice; No-Observed-Adverse-Effect Level; Spores, Bacterial; Taurocholic Acid; Time Factors; Vero Cells | 2013 |
Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserine-cefoxitin-fructose agar (CCFA).
Topics: Agar; Cephamycins; Cholagogues and Choleretics; Clostridioides difficile; Clostridium Infections; Culture Media; Cycloserine; Fructose; Humans; Spores, Bacterial; Taurocholic Acid | 2012 |